June 2, 2020 Research Bulletin

Special Announcements

Cancer Center Update

The University of Colorado Cancer Center hosts advanced technologies needed for cancer research. During the COVID-19 pandemic, researchers in Colorado’s cancer community and beyond are using some of these same shared resources to explore the inner workings of the disease. These discoveries are providing doctors with new tools to diagnose and treat COVID-19.   Here are just a few ways CU Cancer Center technologies are aiding the fight against coronavirus.   

COVID-19 Biobank Initiative

A centralized biobank and governance structure has been created to collect and manage access to COVID-19 positive samples in order to facilitate research in this area at the CU Anschutz Medical Campus.  In addition, a COVID-19 Steering and Allocation Advisory Committee has been established to review applications for these samples.  If you have an interest in research on COVID-19 related samples please visit the website for more information and a link to the COVID-19 Biological Specimens at CU Anschutz application to request access.   

School of Medicine – Student Affairs

The Office of Student Life has a new Microsoft Teams site for faculty to input projects they want medical student help on, as well as posters they have completed but have not made it to publication yet.  This is a tremendous opportunity to get faculty the assistance they need from medical students to complete projects in a more rapid manner while also exposing medical students to different aspects of research efforts.  For more specifics click here.

Limited Submission Grant Opportunities

Edward Mallinckrodt, Jr Foundation Grants

The mission of the Foundation is to support early-stage investigators engaged in biomedical research that has the potential to significantly advance the understanding, diagnosis, or treatment of disease.

• Eligibility: First to Fourth Year tenure track professors
• Application due to Mallinckrodt Foundation August 1
• Materials due to Internal Review Committee June 15
  

FY2021 NIH Director’s Early Independence Award (DP5 - Clinical Trial Optional)

RFA RM-20-014

Supports outstanding junior scientists with the intellect, scientific creativity, drive, and maturity to bypass the traditional postdoctoral training period and launch an independent research career. Applicants must have recently completed or will soon complete her/his doctoral degree or clinical training and have the support and guarantee of an independent research position from a host institution. 

• Limited to two applications per institution
• Materials due to Internal Review Committee June 26
• Application deadline: September 4   

FY2021 NIH Director’s Early Independence Award (DP5 - Clinical Trial Optional): COVID-19 Proposals

RFA RM-20-021

Supports outstanding junior scientists with the intellect, scientific creativity, drive, and maturity bypass the traditional postdoctoral training period and launch an independent research career. Applicants must have recently completed or will soon complete her/his doctoral degree or clinical training and have the support and guarantee of an independent research position from a host institution. 

• Proposal must be relevant to COVID-19 prevention, preparation, or response
• Limited to two applications per institution
• Materials due to Internal Review Committee June 26 
• Application deadline: September 4   

NIAMS Rheumatic Diseases Research Resource-based Centers (P30 -Clinical Trial Not Allowed)

RFA-AR-21-002

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS Resource-based Centers Program (P30) for rheumatic disease research areas within its mission. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on rheumatic diseases. 

• Limited to one application per institution
• Materials due to Internal Review Committee July 6
• Optional LOI Due September 6
• Application deadline: October 6

Featured Funding Opportunities

Robert Wood Johnson Foundation

The Foundation mission is to improve the health and health care of all Americans. The mission is pursued these days through the adoption of the Foundation’s vision – building a national culture of health.     

Pioneering Ideas: Exploring the Future to Create a Culture of Health Program

Proposals accepted on a rolling basis 

Through this new funding opportunity, RWJF seeks to understand and anticipate what dramatic changes we might see in the next five to 15 years in four areas: 

1. Future of Evidence
2. Future of Social Interaction
3. Future of Food
4. Future of Work

Collaborative Research Opportunities

American Heart Association/American Stroke Association

The Henrietta B. and Frederick H. Bugher Foundation and the American Heart Association/American Stroke Association announce 

Request for Applications (RFA) for the Centers of Excellence in Hemorrhagic Stroke 

Research comprising at least three (3) Centers and one (1) Centralized Training 

Center within this Network 

• Full Application due August 27 
• LOI due July 16 
• Materials due to Review Committee June 22

Interested in collaborative research?  Do you have a collaborative research funding opportunity you would like to announce or are you searching for a collaborator on a specific proposal?     

Collaborations between research groups are growing, and the collaborating groups can be across the hall, University of Colorado campuses, the country, or the globe. Scholars or groups in different fields work together on interdisciplinary projects.   

The OVCR wants to offer this space on a bi-weekly basis for promotion of collaborative research funding opportunities (internal and external funding) and solicitations for prospective interdisciplinary collaborators for proposed funding applications.     

Send inquires to ResearchAdminComm@CUAnschutz.edu

NIH Funding Announcements

Just Released

The High-Risk High-Reward Research Program and other Common Fund programs are managed by the Office of Strategic Coordination, Division of Program Coordination, Planning, and Strategic Initiatives in the NIH Office of the Director, in partnership with the component NIH Institutes, Centers, and Offices. The NIH Common Fund encourages collaboration and supports a series of exceptionally high impact, trans-NIH programs. The National Institutes of Health (NIH) –“The Nation's Medical Research Agency” – includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. 

For more information about NIH and its programs, visit the NIH website.     

FY2021 NIH Director’s Transformative Research Award (R01 - Clinical Trial Optional):

Supports individuals or teams proposing that are inherently risky and untested but have the potential to create or overturn fundamental paradigms. An anonymized review process will be used. 

• Open to all career stages
• Application deadline: September 30   

FY2021 NIH Director’s Emergency Transformative Research Award (R01 - Clinical Trial Optional): COVID-19 Proposals

Supports individuals or teams proposing COVID-19-related projects that are inherently risky and untested but have the potential to create or overturn fundamental paradigms. An anonymized review process will be used. 

• Open to all career stages
• Application deadline: September 30

REMINDER 

• Pre-application components are submitted to eBRAP by the Principal Investigator (PI)
• Pre-application submission does not require action by your Business Official/Sponsored Programs Office or equivalent.
  • Breast Cancer Research Program
    • Pre-Application Due Dates June 24/Sept 8
    • Full Application Due Dates Sept 22/Oct 6
  • Melanoma Research Program
    • Pre-Application Due Date June 22 
    • Full Application Due Date Sept 24
  • Multiple Sclerosis Research Program
    • Pre-Application Due Date June 17
    • Full Application Due Date Oct 1
  • Neurofibromatosis Research Program
    • Pre-Application Due Date June 25
    • Full Application Due Date July 14

The CCTSI CO-Mentor program is now accepting applications for review CO-Mentor is an integrated series of four workshops designed to enhance the career development experience for a mentor/mentee pair.   

Evidence-based strategies are used to teach mentor/mentee pairs the skills they need to get the most out of their mentoring relationships.   

Topics include: career mapping and creating a career development plan, setting goals, CV building, establishing the mentor/mentee relationship, and writing effective mentor letters.   

The dates for next year's workshops are: 

• October 2, 2020
• December 11, 2020
• January 22, 2021
• March 5, 2021

Additional information about the program, including past participants and a link to apply, can be found on the CO-Mentor website

This bulletin is distributed on the 1st & 3rd Tuesday of the month for the CU Anschutz Research Community.     

Please click here if you wish to be added to this distribution.